The role of perivascular adipose tissue in vascular smooth muscle cell growth

Abstract

Adipose tissue is the largest endocrine organ, producing various adipokines and many other substances. Almost all blood vessels are surrounded by perivascular adipose tissue (PVAT), which has not received research attention until recently. This review will discuss the paracrine actions of PVAT on the growth of underlying vascular smooth muscle cells (VSMCs). PVAT can release growth factors and inhibitors. Visfatin is the first identified growth factor derived from PVAT. Decreased adiponectin and increased tumour necrosis factor-a in PVAT play a pathological role for neointimal hyperplasia after endovascular injury. PVAT-derived angiotensin II, angiotensin 1-7, reactive oxygen species, complement component 3, NO and H2S have a paracrine action on VSMC contraction, endothelial or fibroblast function; however, their paracrine actions on VSMC growth remain to be directly verified. Factors such as monocyte chemoattractant protein-1, interleukin-6, interleukin-8, leptin, resistin, plasminogen activator inhibitor type-1, adrenomedullin, free fatty acids, glucocorticoids and sex hormones can be released from adipose tissue and can regulate VSMC growth. Most of them have been verified for their secretion by PVAT; however, their paracrine functions are unknown. Obesity, vascular injury, aging and infection may affect PVAT, causing adipocyte abnormality and inflammatory cell infiltration, inducing imbalance of PVAT-derived growth factors and inhibitors, leading to VSMC growth and finally resulting in development of proliferative vascular disease, including atherosclerosis, restenosis and hypertension. In the future, using cell-specific gene interventions and local treatments may provide definitive evidence for identification of key factor(s) involved in PVAT dysfunction-induced vascular disease and thus may help to develop new therapies. LINKED ARTICLESThis article is part of a themed section on Fat and Vascular Responsiveness. To view the other articles in this section visit http://dx

Adipocyte-Derived Factors Regulate Vascular Smooth Muscle Cells Through Mineralocorticoid and Glucocorticoid Receptors

“…Although selective MR stimulation with aldosterone promotes the expression of interleukin 6, PAI-1, and leptin, selective GR stimulation with dexamethasone inhibits interleukin 6, tumor necrosis factor-␣, monocyte chemoattractant protein 1, and leptin expression. [31][32][33][34][35] Although we did not find a role for GR in the increase of VSMC inflammatory markers by ACM, at least in the time period studied, it is possible that GR may be important in settings of chronic stimulation. This awaits further confirmation.…”

Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways

“…1,2 Adipocytes are found in subcutaneous and visceral white and brown adipose tissue and in close proximity to blood vessels, where adipokines directly influence vascular function. 1,[3][4][5][6] Adipokines play a diverse role in adipose tissue biology by regulating adipocyte differentiation, fat storage, lipid metabolism, insulin sensitivity, glucose homeostasis, and inflammatory process. 1,2 Adipocytes may contribute to the pathophysiology of obesity-associated conditions, such as diabetes mellitus, and metabolic syndrome, characterized by perivascular adipose tissue inflammation and endothelial dysfunction.…”

Insufficient Lymph Drainage Causes Abnormal Lipid Accumulation and Vein Wall Degeneration

“…15,16) Vascular wall cells are affected in a variety of ways by inflammation. For example, TNF-α promotes the proliferation of medial smooth muscle cells, 17,18) reduces vascular wall compliance, changes the inner lumen diameter of blood vessels, and causes abnormal blood flow. We considered that excessive accumulation of lipid molecules in lymph would cause adipocytes to degenerate and secrete proinflammatory cytokines, leading to adverse effects on the vascular wall.…”